Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How Do These Drug Companies Really Boost Their Returns?
Motley Fool
Monday, April 25, 2011 - 5:34pm
tags:
Novartis, Teva Pharmaceuticals, AstraZeneca, Sanofi
Billions possibly at stake in SC drug marketing lawsuit against Johnson & Johnson subsidiary
Yahoo/AP
Monday, April 25, 2011 - 5:28pm
tags:
JNJ, South Carolina, antipsychotics, Janssen Pharmaceuticals
Glaxo and Valeant Respond to CRL
Yahoo/Zacks.com
Monday, April 25, 2011 - 5:26pm
tags:
GSK, Valeant Pharmaceuticals, Charles River Laboratories, ezogabine
Sanofi-Aventis gets expanded FDA approval for meningitis vaccine use in young infants
Yahoo/AP
Monday, April 25, 2011 - 5:25pm
tags:
FDA, Sanofi, vaccines, meningitis, Menectra
The Rise Of The Pharmaceutical Un-Sales Force
Forbes
Monday, April 25, 2011 - 5:23pm
tags:
detailing, physicians, drug reps
Studies highlight clot risk with Bayer pills
Fierce Pharma
Monday, April 25, 2011 - 11:18am
tags:
Bayer, birth control pill, Yaz, Yasmin
XenoPort plans study on potential MS drug
Yahoo/AP
Monday, April 25, 2011 - 11:17am
tags:
MS, XenoPort, multiple sclerosis, arbaclofen placarbil
AstraZeneca and Pozen sue generic drugmaker Dr. Reddy's, which seeks to market generic Vimovo
Yahoo/AP
Monday, April 25, 2011 - 11:16am
tags:
AstraZeneca, Pozen, generics, Dr Reddy's, osteoarthritis, vivmo
Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week
Motley Fool
Monday, April 25, 2011 - 11:15am
tags:
Vertex Pharmaceuticals, Merck, Boceprevir, Telaprevir, hepatitis C
A Fight Over How Drugs Are Pitched
NY Times, NY
Monday, April 25, 2011 - 10:42am
tags:
drug reps, physicians
Earnings Preview: Hospira
Yahoo/Zacks.com
Monday, April 25, 2011 - 10:36am
tags:
earnings, Hospira
Why The FDA Issues More Refuse To File Letters
Pharmalot
Monday, April 25, 2011 - 9:38am
tags:
FDA, RTF letters, refuse to file letters
Something to Like About ViroPharma: Management Stock Ownership
Seeking Alpha
Monday, April 25, 2011 - 9:33am
tags:
ViroPharma
Sun Pharma to sell some Merck diabetes drugs in India
Reuters
Monday, April 25, 2011 - 9:21am
tags:
Merck, diabetes, India, Sun Pharma
Spectrum Pharmaceuticals: Pending Approvals Could Send This Stock Flying
Seeking Alpha
Monday, April 25, 2011 - 9:19am
tags:
Spectrum Pharmaceuticals, Fusilev, osteosarcoma
FDA says highly anticipated Merck drug achieved goal of eliminating traces of hepatitis C
Yahoo/AP
Monday, April 25, 2011 - 9:17am
tags:
Merck, FDA, hepatitis C, Boceprevir
Pharmasset 2Q loss widens on costs
Yahoo/AP
Monday, April 25, 2011 - 9:16am
tags:
earnings, Pharmasset
Botox May Deaden Ability to Empathize, New Study Says
Forbes
Monday, April 25, 2011 - 9:15am
tags:
Botox, Allergan
Eisai Aricept Patch for Alzheimer’s Isn’t Ready for Approval
Bloomberg
Monday, April 25, 2011 - 9:14am
tags:
Eisai, Aricept, Alzheimer's disease, Aricept patch
Johnson & Johnson Looks Promising on New Product Potential
Seeking Alpha
Monday, April 25, 2011 - 9:13am
tags:
JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.